Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,957 | 37,841 | 36,383 | 63,542 | 39,933 |
| Marketable Securities | 132,342 | 210,953 | 194,310 | 236,768 | 297,218 |
| Receivables | 40,162 | 38,645 | 40,631 | 39,787 | 39,907 |
| TOTAL | $268,145 | $299,852 | $286,584 | $351,029 | $390,303 |
| Non-Current Assets | |||||
| PPE Net | 37,368 | 32,688 | 25,051 | 15,479 | 12,119 |
| Investments And Advances | 0 | 0 | 42,510 | 0 | 0 |
| Other Non-Current Assets | 43,129 | 44,112 | 44,676 | 47,049 | 26,077 |
| TOTAL | $80,497 | $76,800 | $112,237 | $62,528 | $38,196 |
| Total Assets | $348,642 | $376,652 | $398,821 | $413,557 | $428,499 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,726 | 8,002 | 10,675 | 6,726 | 9,326 |
| Accrued Expenses | 10,575 | 13,547 | 12,830 | 10,630 | 11,603 |
| Other current liabilities | 32,743 | 34,462 | 32,295 | 33,671 | 36,512 |
| TOTAL | $49,050 | $57,535 | $58,231 | $54,608 | $62,407 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 187,776 | 190,303 | 191,675 | 192,835 | 174,208 |
| TOTAL | $187,776 | $190,303 | $191,675 | $192,835 | $174,208 |
| Total Liabilities | $236,826 | $247,838 | $249,906 | $247,443 | $236,615 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,333 | 21,194 | 21,189 | 21,179 | 21,156 |
| Common Shares | 213 | 212 | 212 | 212 | 212 |
| Retained earnings | -345,330 | -323,040 | -294,217 | -271,559 | -240,402 |
| Other shareholders' equity | -29 | 302 | -653 | -667 | -534 |
| TOTAL | $111,816 | $128,814 | $148,915 | $166,114 | $191,884 |
| Total Liabilities And Equity | $348,642 | $376,652 | $398,821 | $413,557 | $428,499 |